Expression of caveolin-3 as positive intracellular signaling regulator on the development of hypertrophy in cardiac tissues |
Kim, Joo-Heon
(Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
Han, Jin (Cardiovascular & Metabolic Disease Center, College of Medicine, Inje University) Kim, Yong-Kwon (College of Biomedical Science and Engineering, Inje University) Yang, Young-Ae (College of Biomedical Science and Engineering, Inje University) Hong, Yonggeun (Cardiovascular & Metabolic Disease Center, College of Medicine, Inje University) |
1 | Colombo F, Noel J, Mayers P, Mericier I, Calderone A. Beta-adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase. J Mol Cell Cardiol 2001, 33, 1091-1106 DOI ScienceOn |
2 | Engelman JA, Zhang XL, Razani B, Pestell RG, Lisanti MP. p42/44 MAP kinase-dependent and - independent signaling pathways regulate caveolin-1 gene expression. Activation of ras-MAP kinase and protein kinase a signaling cascade transcriptionally down-regulates caveolin-1 promoter activity. J Biol Chem 1999, 274, 32333-32341 DOI PUBMED |
3 | Galbiati F, Volonte D, Engelman JA, Scherer PE, Lisanti MP. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activationof p38 mitogenactivated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem 1999, 274, 30315-30321 DOI PUBMED |
4 | Gustavsson J, Parpal S, Kalrlsson M, Ramising C, Thorn H, Borg M, Lindroth M, Peterson HK, Magnusson KE, Stralfors P. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J 1999, 13, 1961-1971 |
5 | Kurzchalia TV, Parton RG. Membrane microdomains and caveolae. Curr Opin Cell Biol 1999, 11, 424-431 DOI ScienceOn |
6 | Marian AJ, Roberts R. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury. Ann Med 1998, Suppl 1, 24-32 |
7 | Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93, 215-228 DOI ScienceOn |
8 | Razani B, Schlegel A, Lisanti MP. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J Cell Sci 2000, 113, 2103-2109 |
9 | Smart EJ, Graft GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 1999, 19, 7289-7304 DOI |
10 | Smart EJ, Ying YS, Mineo C, Anderson RGW. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 1995, 92, 10104-10108 |
11 | Tang Z, Okamoto T, Boontrakulpoontawee P, Katada T, Otsuka AJ, Lisanti MP. Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans. Implication for the molecular evolution of mammalian caveolin genes. J Biol Chem 1997, 272, 2437-2445 DOI ScienceOn |
12 | Toya Y, Schwencke C, Couet J, Lisanti MP, Ishikawa Y. Inhibition of adenyl cyclase by caveolin peptides. Endocrinology 1998, 139, 15693-15701 |
13 | Yamada E. The fine structure of the gall bladder of the mouse. J Biophys Biochem Cytol 1955, 1, 445-458 DOI |
14 | Hong Y, Cho JH, Kim JH. Involvement of calcineurin and Akt/PKB in development of hereditary hypertension. Korean J Vet Res 2004, 44, 7-13 |
15 | Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins a family of scaffolding proteins for organizing preassembled signaling complexes at the plasma membrane. J Biol Chem 1998, 273, 5419-5422 DOI ScienceOn |
16 | Palade GE. An electron microscope study of the mitochondrial structure. J Histochem Cytochem 1953, 1, 188-211 DOI ScienceOn |
17 | Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the arcolemma and co-fractionates with dystrophin and dystrophin associated glycoproteins. J Biol Chem 1996, 271, 15160-15165 DOI ScienceOn |
18 | Watanabe T, Pakala R, Katagiri T, Benedict CR. Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation. J Hypertension 2001, 19, 731-739 DOI ScienceOn |
19 | Boheler KR, Schwartzk M. Gene expression in cardiac hypertrophy. Trends Cardiovasc Med 1992, 5, 176-182 |
20 | Karpen JW, Rich TC. The fourth dimension in cellular signaling. Science 2001, 293, 2204-2205 DOI PUBMED ScienceOn |
21 | Fujta T, Yoya Y, Iwatsubo K, Ouda T, Kimura K, Umemura S, Ishikawa Y. Accumulation of molecules involved in a1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovascular Res 2001, 51, 709-716 DOI ScienceOn |
22 | Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP. Caveolinmediated regulation of signaling along the p42/44 MAP kinase cascade in vivo; a role for the caveolinscaffolding domain, FEBS Lett 1998, 428, 205-211 DOI ScienceOn |
23 | Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995, 92, 1336-1347 DOI ScienceOn |
24 | Hong SH, Ondrey FG, Avis IM, Chen Z, Loukinova E, Cavanaugh PF Jr, Waes C, Mulshine JL. Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J 2000, 14, 1499-1507 DOI ScienceOn |
25 | Pfeffer MA, Frohlich ED, Pfeffer JM, Yunice A, Nordquist JA. Pathophysiological implications of the increased cardiac output of young spontaneously hypertensive rats. Circ Res 1974, 34/35, I235-I242 |
26 | Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996, 271, 2255- 2261 DOI PUBMED |
27 | Zou Y, Komuro I, Yamazaki T, Kudoh S, Uozumi H, Kadowaki T, Yazaki Y. Both Gs and Gi proteins are critically involved cardiomyocyte. J Biol Chem 1999, 274, 9760-9770 DOI ScienceOn |
28 | Anderson RGW. The caveolae membrane system. Annu Rev Biochem 1998, 67, 199-225 DOI PUBMED ScienceOn |
29 | De Windt LJ, Lim HW, Bueno OF, Liang Q, Delling U, Braz JC, Glascock, Limball TF, del Monte F, Hajjar RJ, Molkentin JD. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 2001, 98, 3322-3327 |
30 | Fujimoto TKH, Nomura RUT. Isoforms of caveolin-1 and caveolar structure. J Cell Sci 2000, 113, 3509-3517 |
31 | Ostrom RS, Gregorian C, Drenan RM, Xiang Y, Regan JW, Insel PA. Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem 2001, 276, 42063-42069 DOI ScienceOn |
32 | Taylor JM, Rovin JD, Parsons T. A role for focal adhesion kinase in phenylephrine-induced hypertrophy of rat ventricular cardiomyocytes. J Biol Chem 2000, 275, 19250-19257 DOI ScienceOn |
33 | Nicol RL, Frey N, Pearson G, Cobb M, Richardson J, Olson EN. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 2001, 20, 2757-2767 DOI ScienceOn |
34 | MacLellan WR, Schneider MD. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 2000, 62, 289-319 DOI ScienceOn |
35 | Schlegel A, Lisanti MP. Caveolae and their coat proteins, the caveolins: from electron microscopic novelty to biological launching pad. J Cell Physiol 2001, 186, 329-337 DOI ScienceOn |
36 | Molkentin JD, Dorn II GW. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001, 63, 391-426 DOI ScienceOn |
37 | Uehara K, Miyoshi M. Tubular invaginations with caveolae and coated pits in the sinus endothelial cells of the rat spleen. Histochem Cell Biol 1999, 112, 351-358 DOI ScienceOn |
38 | Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004, 18, 1272-1282 DOI ScienceOn |
39 | Baumann CA, Ribon V, Kanzaki M, Thurmound DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR. CAP defines a second signaling pathway required for insulin-stimulated glucosetransport. Nature 2000, 407, 202-207 DOI ScienceOn |
40 | Gerdes J Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I. Immunobiological and molecular biological characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991, 138, 867-873 |
41 | Sussman MM, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieezorek DF, Molkentin JD. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 1998, 281, 1690-1693 DOI PUBMED ScienceOn |